146 related articles for article (PubMed ID: 1090359)
1. Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy.
Berd D; Cornog J; DeConti RC; Levitt M; Bertino JR
Cancer; 1975 Apr; 35(4):1050-4. PubMed ID: 1090359
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.
Cadman E; Farber L; Berd D; Bertino J
Cancer Treat Rep; 1977 Sep; 61(6):1109-16. PubMed ID: 332346
[TBL] [Abstract][Full Text] [Related]
3. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Durant JR; Loeb V; Dorfman R; Chan YK
Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle agents and cyclophosphamide in the treatment of diffuse histiocytic lymphoma.
Gomez GA; Stutzman L
Eur J Cancer (1965); 1978 Oct; 14(10):1051-5. PubMed ID: 361413
[No Abstract] [Full Text] [Related]
5. Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma.
Sweet DL; Golomb HM; Ultmann JE; Miller JB; Stein RS; Lester EP; Mintz U; Bitran JD; Streuli RA; Daly K; Roth NO
Ann Intern Med; 1980 Jun; 92(6):785-90. PubMed ID: 6992679
[TBL] [Abstract][Full Text] [Related]
6. Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
Cabanillas F; Burgess MA; Bodey GP; Freireich EJ
Am J Med; 1983 Mar; 74(3):382-8. PubMed ID: 6187213
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of non-Hodgkin lymphoma: the diffuse types.
Sweet DL; Ultmann JE
Antibiot Chemother (1971); 1978; 24():125-33. PubMed ID: 350133
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
[TBL] [Abstract][Full Text] [Related]
9. Results of combination chemotherapy of non-Hodgkin's lymphoma.
Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.
Fisher RI; DeVita VT; Johnson BL; Simon R; Young RC
Am J Med; 1977 Aug; 63(2):177-82. PubMed ID: 70170
[TBL] [Abstract][Full Text] [Related]
11. Diffuse histiocytic lymphoma.
Cadman E; Bertino
Ann Intern Med; 1977 Feb; 86(2):244-5. PubMed ID: 319729
[No Abstract] [Full Text] [Related]
12. Diffuse histiocytic lymphoma. The need for aggressive restaging.
Weinerman BH; Levitt M; Babick T
JAMA; 1977 May; 237(22):2403-4. PubMed ID: 323527
[TBL] [Abstract][Full Text] [Related]
13. Advanced diffuse histiocytic lymphoma, a potentially curable disease.
DeVita VT; Canellos GP; Chabner B; Schein P; Hubbard SP; Young RC
Lancet; 1975 Feb; 1(7901):248-50. PubMed ID: 46388
[TBL] [Abstract][Full Text] [Related]
14. Nodular histiocytic lymphoma: factors influencing prognosis and implications for aggressive chemotherapy.
Glick JH; McFadden E; Costello W; Ezdinli E; Berard CW; Bennett JM
Cancer; 1982 Mar; 49(5):840-5. PubMed ID: 7037153
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
17. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin's lymphoma in children.
Brecher ML; Sinks LF; Thomas RR; Freeman AI
Cancer; 1978 May; 41(5):1997-2001. PubMed ID: 348300
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen.
Laurence J; Coleman M; Allen SL; Silver RT; Pasmantier M
Ann Intern Med; 1982 Aug; 97(2):190-5. PubMed ID: 6179448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
